Shah Smital insider trades
Shah Smital has filed 7 Form 4s with the SEC that we hold, for LENZ Therapeutics, Inc. (GRPH) (Director), Pliant Therapeutics, INC. (PLRX) (Director) and Lyell Immunopharma, Inc. (LYEL) (Chief Fin. and Bus. Officer). Across all of them we count 1 purchase worth $100.0K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 5,882 shares of LENZ Therapeutics, Inc. worth $100.0K, dated 2021-06-29. The first filing on our record is dated 2021-07-01 and the latest 2026-03-16.
LENZ Therapeutics, Inc. (GRPH)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-06-29 | P, purchase reported on Form 4 | 5,882 | $100.0K | 2021-07-01 |
Pliant Therapeutics, INC. (PLRX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Lyell Immunopharma, Inc. (LYEL)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1808821) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms